NCT03615326 · Interventional trial
Pembrolizumab/Placebo Plus Trastuzumab Plus Chemotherapy in Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-811/KEYNOTE-811)
Overall registry status Completed
Phase 3
Conditions Gastric Neoplasms, Gastroesophageal Junction Adenocarcinoma
Delaware Valley sites
- Cancer Treatment Centers of America-Eastern Regional Medical Center ( Site 0025) · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory